Doman Group’s Gilead Sciences GILD Stock Holding History

Doman Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$1.61M	Buy	+22,170	New	+$1.53M	1.41%	29

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Doman Group's GILD Position: Q4 2021 in Review

Doman Group opened a new position in Gilead Sciences (GILD) in Q4 2021: 22,170 shares worth $1.61M. The stake represents 1.41% of the portfolio and ranks #29 among its holdings.

1,682 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

Doman Group held 22,170 shares of Gilead Sciences worth $1.61M as of Q4 2021.
Gilead Sciences was a new Doman Group position in Q4 2021.
Gilead Sciences made up 1.41% of Doman Group's portfolio in Q4 2021, its #29 holding.
1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Doman Group's 13F filing for Q4 2021, filed 14 Mar 2022.